Weight Loss Medication Update

You may have heard that from the 23rd June 2025, GPs can prescribe Tirzepatide (Mounjaro) for weight loss.

However, the Birmingham and Solihull Integrated Care Board (BSOL ICB) is still finalising how this will be provided. It is expected to be offered through local clinics, as there has been no planning from the ICB to provide it via individual GP practices.

Initially, the treatment will be available only to people with a BMI over 40 who also have four weight-related health conditions such as high blood pressure, high cholesterol, sleep apnoea, heart disease, or type 2 diabetes.

Please do not book appointments specifically to request this medication at this time, as this service is not yet operational.

For the latest updates, please visit the ICB website: https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.birminghamsolihull.icb.nhs.uk%2Fhealth-information%2Fclinical-pathways%2Fweight-management&data=05%7C02%7Claura.salter1%40nhs.net%7C48e9eba65c9b4305d44a08ddb3c3da56%7C37c354b285b047f5b22207b48d774ee3%7C0%7C0%7C638864375931896675%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=hSFzx7a%2BPmLIE6iK7YmPoDa3AcBUOonWnBhaC98aGho%3D&reserved=0

The ICB’s website is regularly updated as the situation develops.